The Defense Health Agency awarded a $856,523 project grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on the neurovascular and cognitive recovery from the spectrum of traumatic brain injuries through high-low...
This $749,822 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to develop transformative multistaged treatment approaches for composite tissue injuries. The research aims to transform healthcare for military service members, veterans, and the broader public. The award has a performance period from...
The Defense Health Agency awarded a $488,086 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund research on "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS...
This $2,402,721.00 Project Grant was awarded on April 15, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a patient monitoring and decision-support platform for precision health, to be delivered by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). HJF is a non-profit organization that specializes in providing medical research, education, and training services...
The Department of Defense's Defense Health Agency has awarded a $1,390,847 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant, with a performance period from September 1, 2025 to August 31, 2028, will support research to investigate the mechanistic role and therapeutic targeting of the cohesin RAD21 protein in metastatic prostate cancer. As a non-profit organization...
The Department of Defense's Defense Health Agency awarded a $313,151 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on February 15, 2024, supports a 2-year research project titled "AUGMENTING RET KINASE SIGNALING IN INTRINSIC NEURONAL REPAIR RESPONSES TO TREAT TRAUMATIC BRAIN INJURY". HJF, a global non-profit organization focused on...
This federal Project Grant award of $1,030,660.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded on Sep 30, 2024 to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. to support research aimed at "LINKING SUCCESSFUL OSSEOINTEGRATION WITH SENSORIMOTOR CONTROL". The grant will fund a 4-year research project focused on exploring innovative approaches to improving...
The Department of the Army Medical Command awarded a $1,898,000 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the development of a rapid, field-deployable nanopore sequencing-based assay to improve clinical decision-making and patient management for military personnel and the general public. The 3-year project aims to advance diagnostic and...
The Department of Defense's Defense Health Agency awarded a $783,023 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant supports a 3-year research project titled "A Precision-Medicine Approach to Targeting Acquired Therapeutic Resistance in RTK-Mutated NSCLC". This research aims to transform healthcare for military service members, veterans, and the broader...
The Defense Health Agency awarded a $478,061 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This grant, with a performance period from September 1, 2024 to August 31, 2026, supports the development of an organoid model for ovarian cancer research and precision medicine. The Henry M. Jackson Foundation, a global non-profit organization, will use this funding to advance...